Intravenous phentolamine mesylate alleviates the pain of pancreatic carcinoma.
This case report describes the successful alleviation of the pain of pancreatic carcinoma with intravenous phentolamine mesylate. A 2 day infusion gave relief for 26 days on the first occasion and for 12 weeks after the second infusion. The possible mode of action is discussed.
McCleane
Gary J
GJ
Craigavon Area Hospital Group Trust, Craigavon, BT63 5QQ, Northern Ireland, UK.
D000328:Adult; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D010146:Pain / Q000188:drug therapy*; D010190:Pancreatic Neoplasms / Q000150:complications*; D010646:Phentolamine / Q000627:therapeutic use*
D018712:Analgesics, Non-Narcotic; D010646:Phentolamine